{
  "ticker": "JNJ",
  "date": "2025-11-03",
  "lookback_days": 14,
  "fetched_at": "2026-02-13T12:02:46.338063",
  "source": "alpha_vantage",
  "article_count": 50,
  "articles": [
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee replacement division, DePuy Synthes, into a stand-alone company within 18 to 24 months. This strategic move aims to enable J&J to focus on higher-growth businesses. The orthopedics unit was chosen for separation due to its lower growth rate and profit margins compared to other medical-device segments.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqfkf7MhWwsJ8v5Zp0OfESV3-FwoOXhW_GOWRgb1V54iXGQzOYCNrXq8&gaa_ts=69093d4e&gaa_sig=keBP1ZF5OeWdpEQ1SDs6HzcdOyIJ3f0eggHYszizVKmImGDVhKrZJTdB75WTcotg-PrGCQ0XcMWJWmoV8XTOaQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T232646",
      "overall_sentiment_score": 0.137736,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment_score": 0.146053,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, currently branded as DePuy Synthes, into a stand-alone company within 18 to 24 months. This strategic move aims to allow J&J to focus on faster-growing business segments, as the orthopedics division has experienced lower growth and margins compared to other medical-device units. This separation is part of J&J's ongoing efforts to streamline its operations.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcrqQ8zQQC-ds7XaY-xbb4sNnaNf-mBvp2d-UqhcOGGFRhU74SAeAN0&gaa_ts=69093af3&gaa_sig=LGG8pE2Yh1k_koJtYW0JDYZ7ruHuQyMY3ldXsL10cqSIzRDlIHNbTXvLCycM2pvtsd5AvA2fYoKnrAbh7hRYPA%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T231650",
      "overall_sentiment_score": 0.153465,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.254182,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, currently known as DePuy Synthes, into a stand-alone company within 18 to 24 months. This strategic move aims to allow J&J to focus on faster-growing segments, as the orthopedics division exhibits lower growth and margins compared to other medical-device units. This separation is part of the healthcare giant's ongoing efforts to streamline its operations.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqebFW7PtOrHXplotDYBFwVcnfHRLGwJyCjrElg2ykXs3euu-QztxlqD&gaa_ts=69093775&gaa_sig=B10-vPYrAdCGicXtNgOk9qBS45Qg5TghBq6ehM4Mp_Yxi1aeD20X-XOu-DEfCNUsarrQiKZbWsNMS1Uj4BjPFw%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T230153",
      "overall_sentiment_score": 0.206166,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.221315,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to spin off its artificial hip and knee replacement division into a new stand-alone company called DePuy Synthes within 18 to 24 months. This move is part of J&J's strategy to streamline its operations and focus on faster-growing businesses. The orthopedics unit is being separated due to its lower growth and margins compared to other medical-device segments like heart devices, surgical products, and vision care.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdfhALSERty59HCL2hYqzUV18vQPByJOGXJaKK6FzV9f-DesIwP0BdU&gaa_ts=69093194&gaa_sig=UcK2AiPtWGF8O1wpLZCLof72xm9SjCecQ543ZRu8cpLHIp8hDewqDbx_z1-xvKCEIS8OGZ9eNcVl9f00yjfyRw%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T223654",
      "overall_sentiment_score": 0.148447,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment_score": 0.138011,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson plans to spin off its artificial hip and knee business, DePuy Synthes, within 18 to 24 months, indicating a strategic move to focus on faster-growing segments. This separation is driven by the orthopedics division's lower growth and margins compared to other medical-device units within the company. This move reflects J&J's ongoing efforts to streamline its portfolio.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqf69eWS2JzH7IKYMFLS-_ZpQ0g4S_bXU5iYXnHT9oSIF-ljv80hSovY&gaa_ts=69093066&gaa_sig=RlERG0F9dDwgRfWXPhGGNPHKYY4rRQv6nWS458B5vE5_o3LuMf-IpqAQVSmovOPbgAX3IlzvAr2YkBF43fgtbQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T223141",
      "overall_sentiment_score": 0.254671,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.254163,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to allow J&J to focus on higher-growth and higher-margin businesses within its medical-device unit. The company is exploring options for the separation, including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdSdW3stzIDjSaJi-bM-HS7aGqN82keEar7VaOL7VBZMTImW-h0IRb7&gaa_ts=69092e0e&gaa_sig=vCEltPKfgKPI2hgfk3rShpHdd8agED6j6f7nIWgsfiv_ufS8aNoPCFHmEVvt5Mw2yy51iUfvFQgAQNvQPa9QMQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T222148",
      "overall_sentiment_score": 0.276626,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.281307,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move is part of J&J's strategy to focus on faster-growing businesses, as the orthopedics division has lower growth and margins compared to other medical-device units. The separation aims to streamline the healthcare giant's portfolio.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcurnG-f_x4Oa2nf476F9XwtzbpqsqwCh_xLhmWFR9HTO0nSVwkhl_2&gaa_ts=69092832&gaa_sig=8_Av5W-FaoowSjg8i7T91lnrwHH88V1z_69k2Wdoxbc3Wjon0z98ppEMzawAKQod0fdsYoHgNn-ZIBW8DzvviQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T215638",
      "overall_sentiment_score": 0.22568,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.221992,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson plans to spin off its artificial hip and knee replacement business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to focus J&J on faster-growing businesses, as the orthopedics division has lower growth and margins compared to other medical-device units like heart devices and surgical products.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdA1rz_sZNmP1qpGupH-Osqoa7gYc2fdqVV_BU5K0dvtEePrdq6EKkz&gaa_ts=690925de&gaa_sig=u69lI69Wa1ZuT8ph0SDkiW3Vxwvvnh_G0GcAvCN_-CgsVJFTos4jvOnH6SAp8Dix3Y8cN85GqYbCUO6IRcWAVg%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T214701",
      "overall_sentiment_score": 0.293337,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.2624,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, currently a part of its DePuy Synthes division, into a new stand-alone company within 18 to 24 months. This move is part of J&J's strategy to streamline its operations and focus on faster-growing businesses, as the orthopedics unit has shown lower growth and margins compared to other medical-device segments.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcgRM1bmDWLpH8ZRolb0V64Q1yduJg-lS1cnwmhmL3PQSqOMNhW743H&gaa_ts=69092386&gaa_sig=We05nK6JlewduJNaytRhWTGRaI7iPp2-gPRPfPI2gH4I_iq2SJj4laY8TmJpcRb-Z2qbuauSQJjZo3dbqm6-kg%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T213657",
      "overall_sentiment_score": 0.253188,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.266787,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to streamline J&J's focus on faster-growing businesses, as the orthopedics division has experienced lower growth and margins compared to other medical-device units. The company will explore options for this separation, including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdSGxn62eIhTdwXMEE-9rZEtsx8FSI094gwL9SLeqc9D_aBy-GN3RJO&gaa_ts=69092255&gaa_sig=VbuGdl0d0K8Ko1m_FzJQCmzUp2zjGXNKFY5J8thtQRp7v2pB1uwvURrumGKa3rtUO-fT4tTBJtvnvWxjbz5Gow%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T213149",
      "overall_sentiment_score": 0.2582,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.260162,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced its plan to spin off its artificial hip and knee business, DePuy Synthes, within 18 to 24 months, making it a stand-alone company. This strategic move aims to allow J&J to focus on faster-growing segments of its medical-device unit. The orthopedics division is being separated due to its lower growth and margins compared to other parts of J&J's medical device portfolio.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqe-m_E0lv1c96_pqwimbAXDQmZR0owewjfXAvf7lDp-Bml1B4axZZIW&gaa_ts=69091da9&gaa_sig=XcsnZHy41oLnf8uIvH5HRHzE0P5MmEL5bvRb207TEPJKX1lKMABw6oU3sIpgn8lIwhUc0zS8bQQnLv6P50cVkg%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T211205",
      "overall_sentiment_score": -0.203638,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment_score": -0.182917,
      "ticker_sentiment_label": "Somewhat-Bearish",
      "relevance_score": 1.0
    },
    {
      "title": "J&Jâ€™s Shockwave reports positive IVL data for below-the-knee lesions, CLTI",
      "summary": "Johnson & Johnson MedTech's Shockwave Medical announced positive one-year results from its DISRUPT BTK II study, evaluating the Shockwave peripheral IVL system for calcified lesions below-the-knee, especially in patients with chronic limb-threatening ischemia (CLTI). The study demonstrated symptom relief, limb salvage, and improved quality of life, with high rates of freedom from major amputation and clinically driven revascularization. These findings highlight the critical role of IVL in wound healing and limb preservation for complex arterial disease patients.",
      "url": "https://www.massdevice.com/shockwave-positive-ivl-data-btk-clti/",
      "source": "MassDevice",
      "published": "20251103T204450",
      "overall_sentiment_score": 0.418438,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment_score": 0.447523,
      "ticker_sentiment_label": "Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, currently known as DePuy Synthes, into a stand-alone company within 18 to 24 months. This strategic move aims to allow J&J to focus on faster-growing and higher-margin businesses. The orthopedics division is being shed due to its lower growth and margins compared to other medical-device units like heart devices, surgical products, and vision-care products.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqfm7yKfdR5fs7HlXf8wT-tdaCBjwAnkMRTvCBJWHkPKO3KS8oIUTx-u&gaa_ts=69091446&gaa_sig=roF8D_d1bLXKAXEo9RfEClGZkubNiYqY2ARHHa1Hffl070DpExMne-_9bCZ3RtPDLA7mYGXr9jy4q2INIbGzrw%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T203211",
      "overall_sentiment_score": 0.256912,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.296521,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced its plan to spin off its artificial hip and knee replacement business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to allow J&J to concentrate on faster-growing and higher-margin sectors within its medical-device unit. The company is considering various options for the separation, including a potential spinoff to its shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdg49lQKcQrTbirFKqTUb57H--RzGQB4xrpGxh-z_yLZXrlqzccvUCm&gaa_ts=6909131d&gaa_sig=ltqdDNgHWgaAtTaNZ3Oluq_f9MpmjrzDsqsACIARhGIdtE1bMh0ZapCRM0kM3IKIX8_mfpP0Lc2mB3qtvicSLQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T202705",
      "overall_sentiment_score": 0.263551,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.261548,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson plans to spin off its artificial hip and knee business, DePuy Synthes, within 18 to 24 months to become a stand-alone company. This move is part of J&J's strategy to streamline its operations and focus on faster-growing business segments. The orthopedics division was identified for separation due to its lower growth and margins compared to other medical-device units.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcRstv5wd06oWGcYkd2dfWneoFKFwXV-jrEkpo_bKUWx_CPWOBxzEDk&gaa_ts=69090e6d&gaa_sig=6jhJjkBbmg3tKLmnfh1MBUYZz5AUHfTl1AyVA9YSo0ziLvB7rRKg1wcqW7nm8br4HkOlM__UFBTWcMw8mIyUcw%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T200709",
      "overall_sentiment_score": 0.13176,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment_score": 0.127418,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to spin off its artificial hip and knee business, DePuy Synthes, within 18 to 24 months. This move aims to focus J&J on faster-growing businesses as the orthopedics division has lower growth and margins. The company is considering options like a spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqeEi2ihAtklz1M2l0zVkgcz46B7U1ciraeLHgJ6url4Y4iLh9eh_40d&gaa_ts=69090ae6&gaa_sig=2wrXp-o_XRSewFSCNjXobGM2z_spy_naJ6f17EaTUB8mTAb9UcjssOw4nZiVkdw9MFQfog5kRoSPzVXZxkRL-A%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T195139",
      "overall_sentiment_score": 0.197586,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.169614,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced its plan to spin off its artificial hip and knee replacement division into a new stand-alone company called DePuy Synthes within 18 to 24 months. This strategic move aims to allow J&J to focus on higher-growth, higher-margin businesses within its medical-device unit. The orthopedics business was identified as having lower growth and margins compared to other sectors like heart devices, surgical products, and vision-care products.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdMJPb4bhZDKK3rr61EO0DpknEe52fOc_qR0k5Ai2-vg5SQWdUijUPR&gaa_ts=690909b8&gaa_sig=mgrzidikut8SogHM9GbXZ7vr-LyCyCtefRcQLQJntCH2lG9_QxEaIU0tQBt5cWcv64XwuJmt649q2OQO_WNsHw%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T194653",
      "overall_sentiment_score": 0.294553,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.279844,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to allow J&J to focus on faster-growing and higher-margin businesses within its medical-device unit. The company is considering options for the separation, including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqesZwSuSVz7Y-J92-ljtUj0fY14niVo2DrcUSUISakxHzy7ToCW96MH&gaa_ts=6909050c&gaa_sig=aWtzTRO6mfh3AGWLWsVqluBGQOCif6cnhHwoO2GgFOiVsoDtjHZYTVxCd2aUdg0pIqYOqu9GmqO4ipADajLccw%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T192654",
      "overall_sentiment_score": -0.103229,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment_score": -0.136993,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move is part of J&J's broader strategy to concentrate on faster-growing businesses and improve its overall margins, as the orthopedics division has experienced lower growth and profitability compared to other medical-device units.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdpFi_KDbLdQGhQa1xIBcBUCEUeYU0P0ISL9Eqhe8NZP6FP6M4Ag4bQ&gaa_ts=6909005b&gaa_sig=WyzTZW2iwFc4KosoeBtXNZQBBaIZxTlS6yqHsgt1JX9GepzCAuT75ra9l1nYymcD5ae5htW2USPtoWX6QL3wNg%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T190654",
      "overall_sentiment_score": 0.167756,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.256325,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move is part of J&J's strategy to focus on faster-growing businesses, as the orthopedics division has lower growth and margins compared to other medical-device units.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcerdq3OYi5E5YERL9MDGp_JAaAI5uPHnsoGu2sOg-LGJO55c2XytW5&gaa_ts=6908fcd5&gaa_sig=p3-tcz4jYfFF0sO4aAMgQws-713n2ApFa3Zh15Z0HU7WURO-pPczQychVW2bozAAUBqc04_8aL65m0rK0LZvvw%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T185140",
      "overall_sentiment_score": 0.286254,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.272989,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson plans to spin off its artificial hip and knee replacement business, which will operate as a stand-alone company called DePuy Synthes within 18 to 24 months. This move is part of J&J's strategy to focus on faster-growing businesses, as the orthopedics division has lower growth and margins compared to other medical-device units.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqeb0VSYimLiHm5V0yLj7kv7gDeN5nteYm32Bo2KzROUG001dpRL-_KL&gaa_ts=6908fba8&gaa_sig=hFdgGvthWF4hFdLZE2mz7RHMztuqMYpUmQSmsh-rb-z4-w3pKCDbvmvmbrABTMfD2xiWkao1VZ4LSTqIfe8Cyg%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T184647",
      "overall_sentiment_score": 0.321983,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.312064,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to allow J&J to focus on faster-growing businesses as the orthopedics division exhibits lower growth and margins compared to other medical-device units. The company is considering options such as a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqeK_8-KnOtnjP2ySYhiFnfE96Lj7jqnVXcwEbnLcSpnC3_PIEP-GMZ8&gaa_ts=6908f956&gaa_sig=ntYUqmMNxuTb1ywtF1YSpNZZ9asSLB2XZnVgYzaiS3MUR7mWNoq0rIjVws_IxRItMkUrXvqbtjJ-Kdxozr4OWg%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T183650",
      "overall_sentiment_score": 0.181711,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.294766,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to allow J&J to focus on faster-growing businesses, as the orthopedics division has lower growth and margins compared to other medical-device units. This separation is part of J&J's strategy to streamline its operations.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcPGP-lZpz9qZnNFENq7y6MwU_y52ynnLHseH5CtyG58Xx5g56gggBG&gaa_ts=6908eec6&gaa_sig=t_XYLwZV4N872h6VhlEjU-au2Dqt64ffilp-oeST0N4TcQJFIuJHra2ASqSdnKUzW3JseIYkKA0gnIp5nrmKTA%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T175149",
      "overall_sentiment_score": 0.271242,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.250441,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move is part of J&J's strategy to concentrate on faster-growing businesses, as the orthopedics division exhibits lower growth and margins compared to other medical-device units.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqc3gL9iUaU-4dE70L86vfWIP-z2CU5R1clhUrqKf7BTwCBDF3myMYTN&gaa_ts=6908e565&gaa_sig=VkuvMQExj38goy-m16xTxcRSFtI9KoNoaP_3ky0crbQPmsbEejM8_xDGRhouw8qpyubZ98-DIib5XsXwb43GXw%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T171141",
      "overall_sentiment_score": 0.289768,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.275253,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced its plan to spin off its artificial hip and knee replacement business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to allow J&J to focus on faster-growing businesses. The orthopedics division is being separated due to its lower growth and margins compared to other medical-device units.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdCvxWHKzdmX1xyMWC4cz-Qn_f0LFGGWZToO2xtUqQITjbskob5o3aA&gaa_ts=6908e43a&gaa_sig=qVxNz5QOS-UEsMH-ZbdwJUWA1ET50qUjTEOqHwcI3apPBiiCRsYJW3U7Q6BA3nL6ViYgL209Rn97nd8XLNtWqQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T170649",
      "overall_sentiment_score": 0.295423,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.259383,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee replacement business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move is part of J&J's strategy to focus on faster-growing businesses, as the orthopedics unit has lower growth and margins compared to other medical-device segments.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcKneRGZw86EKfo5maQ5XqNAzCJvXz-8f1KiJlBkqEzRGkyTbiV8mbg&gaa_ts=6908e1e2&gaa_sig=L_N_j0-KcMKJOzTiuwiwMBQUWkJHQ_tQhpgVZLp4XoOXC8bONDjsfj2clPfAtrdA08yG2_fmVRgiNM0cW3PiCQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T165634",
      "overall_sentiment_score": 0.214945,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.309755,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced its plan to spin off its artificial hip and knee replacement division, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to allow J&J to focus on faster-growing, higher-margin businesses within its medical-device unit. The company is exploring options for the separation, including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcNsuQwiIqy4wi3HznExIfJKk50hq0742xjOWqJSiFB8Ind6eRT8eD9&gaa_ts=6908df8a&gaa_sig=I3fpOv5bFjtG9tTDmdiATaSsObl1A3tdEB9NlQXOE1NlbMOGzh-7GzNdV6WkNmdxvelXVonkKvZdC96I8Ia7Sg%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T164701",
      "overall_sentiment_score": 0.270282,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.293666,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to allow J&J to focus on faster-growing businesses, as the orthopedics division has lower growth and margins compared to other medical-device units. J&J is exploring options for the separation, including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqd4yINKu-xhPhmne_cLsUUcDhUfWlosgro9NqWgnnoUtBjy4G1uybwf&gaa_ts=6908dc04&gaa_sig=lG1LBvo7v0igHa5e6MuI_HW9iO8vRDYmZtqArYXZCwF_WFd9uDID4VoJZYqwfcl0a8PRDJuzAyre7D3ZhxyORA%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T163136",
      "overall_sentiment_score": 0.343382,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.344906,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson plans to spin off its artificial hip and knee replacement business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This strategic move aims to enable J&J to focus on its faster-growing businesses, as the orthopedics division has lower growth and margins compared to other medical-device segments like heart devices and surgical products. The separation aligns with J&J's broader efforts to streamline its operations.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcrYD6PP-YlWSKPoM7-CK0gb2yXPIWv6vIgyKyQYFO3JYATlEMQbXC8&gaa_ts=6908dadb&gaa_sig=xwTU9eyA5de9ay36FVNdLt57ZExV8RXPc7AIyVUPNkN2Db8annLmpXbeEfIohMalE3EV-Anpyl8_DuEauR-tWw%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T162656",
      "overall_sentiment_score": 0.230174,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.209224,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced its plan to spin off its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This strategic move aims to enable J&J to concentrate on its faster-growing and higher-margin medical-device segments. The company's CFO, Joseph Wolk, highlighted that the orthopedic division, while a steady grower, does not outperform other parts of the medical-device unit.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdD_hluMDmN-DZMBwsp-BIi7picOfQaNMuF-foNXxJixZ9PmLkJc0gD&gaa_ts=6908d9b1&gaa_sig=iIlfL4KV3CcU-su-w4eA0t0ivUvFY7qyQfKGwiPTtQoKcPZemb9Sy045oQmprQrh0cUw78pHr_jAeg7WEzeapQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T162149",
      "overall_sentiment_score": 0.279264,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.268273,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to spin off its artificial hip and knee business, DePuy Synthes, within 18 to 24 months, to become a stand-alone company. This strategic move aims to allow J&J to concentrate on its faster-growing and higher-margin businesses within its medical-device unit. The orthopedics division was identified for separation due to its lower growth and margins compared to other J&J segments.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcpGVCnqVlHQww7Wd9JHv6gjAqtZ7zHccllvBa3cIM2KP0y3qSgcEbE&gaa_ts=6908d500&gaa_sig=nz-BIuGqqMHwnyhpbCKmE0o91pr8bk9-1Tl2D14NER8CFslvIMS5yA1TVcyKHuwzNLCRy51Vg_aUv1c2PRv1lg%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T160152",
      "overall_sentiment_score": 0.261195,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.286544,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move is part of J&J's strategy to concentrate on faster-growing business segments, as the orthopedics division exhibits lower growth and margins compared to other medical-device units.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqc7pG0H0X2xApMZGk_FjU8a17v92RbmmsALip1oLs3WBpmkE9SIA6cm&gaa_ts=6908cdf4&gaa_sig=55tj9WOoq4JUzib8s6X6UeGH8S8E9LshFmK7-0qJR1DG-6lp7hNR3uCHHyv3wSxUONYG2KQ05wOSfpZlmWBaUQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T153142",
      "overall_sentiment_score": 0.144292,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment_score": 0.114058,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to streamline J&J's focus on faster-growing businesses, as the orthopedics division exhibits lower growth and margins compared to other medical-device units. J&J is exploring various options for the separation, including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcGxhFW3lwMHfqul_xYSw8YiIC0xixN4qNF8lp_yvxh3-omrJz2tMiS&gaa_ts=6908cccb&gaa_sig=Q3S-L3E0Fv0OimIGZhc6VG69NoWuN2qpLk_E_MkMkY4-S4y48BiFzuPt2-fUC_-Oxk4zPI6D6NMTQUoZvQBHpA%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T152649",
      "overall_sentiment_score": 0.287637,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.288444,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This strategic move is part of J&J's effort to streamline its operations and concentrate on faster-growing business segments. The orthopedics division is being shed due to its lower growth and profit margins compared to other parts of J&J's medical-device unit.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqe_i0bFnwt3eepj6nk8kdzX9ZSI0sKSrYihay4gPJlqknQcacW6X_or&gaa_ts=6908c81c&gaa_sig=fhekytjuczTegDdZNU0QLba_tnrCpH91j-U4Xq9T-Dlxz5Z5FXQbA2I8TH-QmSZboRZcwgFSGoylX1O5q76QeA%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T150713",
      "overall_sentiment_score": 0.141291,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment_score": 0.105306,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced its plan to spin off its artificial hip and knee business, DePuy Synthes, within 18 to 24 months, as it focuses on faster-growing segments. This move is driven by the orthopedics division's lower growth and margins compared to other medical-device units. This separation marks a continuation of J&J's efforts to streamline its operations.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqe6S7YYElg7v8imNnGmqsuqYqGBBFbqZoOT5lveLB1fcCNo59vsSnrR&gaa_ts=6908c496&gaa_sig=nLnTNP5rz1s0AverlRgW_tHAM8y6JVni5lEwOP9aDjVu8s-Of8E_J4daJemjB8bZ5sM8F2orPNJN2EY3t17v9Q%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T145201",
      "overall_sentiment_score": 0.218218,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.239929,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to streamline Johnson & Johnson's operations and allow it to focus on faster-growing and higher-margin businesses. The split is being considered due to the orthopedics division's lower growth and margins compared to other medical-device units, with options including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqckd7g4ZKkJRXl_J2mtNYsqUiYlJgv_BMkcq3sY4dtwmiBqIk51am1q&gaa_ts=6908c370&gaa_sig=kSwzEV6_PB1A5CMU5_Bd69iJNW9XX4tPedcnduzrWHWfmo8ijzbil9ty7zXADDQPyIwXjbFTJ8vmuY2YdNDuMQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T144717",
      "overall_sentiment_score": 0.284127,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.274686,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson plans to spin off its orthopedics business, DePuy Synthes, within 18 to 24 months. This move aims to focus J&J on faster-growing businesses as the orthopedics division has lower growth and margins compared to other medical-device units. J&J is exploring options for the separation, including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqcC3Jt2pPFj6fQyS_buF073S2DxvySobdtLqB5ribxQMMjj5I38Plfl&gaa_ts=6908c23e&gaa_sig=VFjYDHqer1W0vjjycImKffuJD3d4XugycZHbSJdClTrzypffm6h_6iJXbtoPx6u9IkEsCTRj9py893WnBUE_bQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T144157",
      "overall_sentiment_score": 0.321157,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.327127,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee replacement division into a new stand-alone company, DePuy Synthes, within 18 to 24 months. This move is part of J&J's strategy to focus on faster-growing businesses, as the orthopedics unit has lower growth and margins compared to other medical-device segments.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqeWIY6t1Bhwxqi7iPNpjLp_F8NVDxOtl43_2u7iI7t8PHRwPF63sBgF&gaa_ts=6908bfe6&gaa_sig=inqfErOkVNLKpuDxZ-Y8Rdz53z0ZfWl4uBaBDmIErtDyHxEWUgo2UysfhWQrgTSI5Asm2kLYOptrSG7ZRzfP0g%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T143136",
      "overall_sentiment_score": 0.295704,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.258741,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced its plan to spin off its artificial hip and knee replacement business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to allow J&J to focus on faster-growing and higher-margin businesses. The orthopedics division was selected for separation due to its comparatively lower growth and margins within J&J's medical-device unit.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdcgOUwhVM2iOXatrCGeDWXGaeY-Ud89tLCDNc71WTJO44Lj5pr9lth&gaa_ts=6908b0ab&gaa_sig=gDSVYmnnpCdDEBaw5aSSqyGmutl4imkwVgyoyyHzC_pouruZwueYpQhACLT1QYP-GTViLUXVrJ3P1wX0-2BKIQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T132644",
      "overall_sentiment_score": 0.142846,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment_score": 0.124758,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson $JNJ Shares Bought by Bank of New York Mellon Corp",
      "summary": "Bank of New York Mellon Corp increased its stake in Johnson & Johnson (NYSE:JNJ) by 2.7% in Q2, making JNJ its 20th biggest position. Other institutional investors also adjusted their holdings. The article details recent analyst ratings, reflecting a \"Moderate Buy\" consensus, insider selling by EVP Jennifer L. Taubert, and financial performance data for Johnson & Johnson.",
      "url": "https://www.marketbeat.com/instant-alerts/filing-johnson-johnson-jnj-shares-bought-by-bank-of-new-york-mellon-corp-2025-11-03/",
      "source": "MarketBeat",
      "published": "20251103T132519",
      "overall_sentiment_score": 0.33339,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.485361,
      "ticker_sentiment_label": "Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson plans to spin off its artificial hip and knee replacement business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to streamline J&J's operations, focusing on faster-growing segments. The orthopedics division is being separated due to its lower growth and margins compared to other medical-device units.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqeB-IxJkxyHCXqZQ_n9HnFvm6zR47tIFizLEv_5vhy3IBNbAIGXdmzb&gaa_ts=6908ae57&gaa_sig=gOHl0PIy_EKv2CcwWFUFWW7oo6Gw9of82jI3YQfUUdsQHy7uK1naMLVbWZb0bQjkvQmj01QHSP4rOcQKq2YSQQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T131647",
      "overall_sentiment_score": 0.381931,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment_score": 0.419207,
      "ticker_sentiment_label": "Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced its plan to spin off its artificial hip and knee replacement business, DePuy Synthes, into a stand-alone company within the next 18 to 24 months. This strategic move is aimed at allowing J&J to focus on its faster-growing businesses, as the orthopedics division has lower growth and margins compared to other medical-device units. The company is considering various options for the separation, including a potential spinoff to its shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqeYKooSGQV70VCMOzKIW2VplDjzWfe-pCu93YNxSjUckoHbGY4EQZNj&gaa_ts=6908aad1&gaa_sig=JqeUTIOHk0p46TV3MLIQKNpFN6KoEoJ0PfHOBQgfdViSOs6tb8jgVM4cwXM3HP2Sp5dvX0yl8rjNEZFU9ELBig%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T130158",
      "overall_sentiment_score": 0.298523,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.269773,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to help J&J focus on faster-growing and higher-margin businesses, as the orthopedics division has experienced lower growth compared to other medical-device units. The company is considering options for the separation, including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqeZXQCnktdSGLwC7zxmWovNbXMUarzagG2f1InSimNyW_Yu8dEKFAW_&gaa_ts=6908a74d&gaa_sig=aLKmDnVhOSZHLwKNGgQZkwWTw2QzfC_9dopbM6JU8iFHqsQzVX2evnMRaNEOk952ID1MvY2UqWFMXuC6T0D1hQ%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T124659",
      "overall_sentiment_score": 0.295876,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.27716,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee replacement business into a new stand-alone company, DePuy Synthes, within 18 to 24 months. This move is part of J&J's strategy to focus on faster-growing businesses, as the orthopedics division has lower growth and margins compared to other medical-device units.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqdiZTxrOFDkB48-cl5qlEevWtyERfhiWnUo65fQSJuyAXO0VrLFelxu&gaa_ts=6908a3c9&gaa_sig=J-WUdifbp1w73zdANFLaHCOC4EWX2sHLe_HdsDKAdZO7qdrNMwql-SEkGy1OKUadOzTyIUb90tHsAVQTu1LWdA%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T123200",
      "overall_sentiment_score": 0.273924,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.29775,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 1.0
    },
    {
      "title": "Corporation building Warren plant to buy maker of Tylenol",
      "summary": "Kimberly-Clark, currently establishing an $800 million plant in Warren, announced plans to acquire Kenvue, the company behind Tylenol, Listerine, and Neutrogena. This acquisition will merge two large American companies, creating a health and wellness powerhouse with an estimated yearly revenue of $32 billion and featuring ten iconic brands each generating over a billion dollars in sales. The deal, valued at approximately $48.7 billion, is expected to finalize in the second half of 2026, pending shareholder and regulatory approvals.",
      "url": "https://www.wfmj.com/story/53209113/corporation-building-warren-plant-to-buy-maker-of-tylenol?clienttype=mobile",
      "source": "WFMJ.com",
      "published": "20251103T140727",
      "overall_sentiment_score": 0.341355,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.215446,
      "ticker_sentiment_label": "Somewhat-Bullish",
      "relevance_score": 0.735198
    },
    {
      "title": "Tylenol Maker Kenvue Acquired For Billions",
      "summary": "Kimberly-Clark has announced its acquisition of Kenvue, the maker of Tylenol, in a cash and stock deal valued at $48.7 billion. This acquisition brings brands like Aveeno and Listerine under Kimberly-Clark, while Kenvue is also embroiled in lawsuits regarding alleged links between Tylenol and autism, claims which Kenvue strongly disputes.",
      "url": "https://bobbybones.iheart.com/content/2025-11-03-tylenol-maker-kenvue-acquired-for-billions/",
      "source": "The Bobby Bones Show",
      "published": "20251103T140727",
      "overall_sentiment_score": -0.151076,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment_score": -0.446343,
      "ticker_sentiment_label": "Bearish",
      "relevance_score": 0.705082
    },
    {
      "title": "Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal",
      "summary": "Kenvue, the maker of Tylenol, missed Wall Street estimates for third-quarter sales, while simultaneously announcing its acquisition by Kimberly-Clark for approximately $48.7 billion. The company has faced challenges, including an 11% decline in Tylenol sales following controversial comments linking the drug to autism, and a 3.5% decrease in overall net sales to $3.76 billion. Kenvue also named Kirk Perry as its new permanent CEO and reiterated its 2025 adjusted profit outlook.",
      "url": "https://www.reuters.com/legal/litigation/tylenol-maker-kenvue-misses-sales-estimates-amid-kimberly-clarks-487-billion-2025-11-03/",
      "source": "Reuters",
      "published": "20251103T132700",
      "overall_sentiment_score": 0.195304,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.021739,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 0.703224
    },
    {
      "title": "Corporation building Warren plant to buy maker of Tylenol",
      "summary": "Kimberly-Clark, which is building an $800 million manufacturing facility in Warren, plans to acquire Kenvue, the maker of Tylenol, Listerine, and Neutrogena. This deal, valued at approximately $48.7 billion, will merge two large consumer health companies, creating a powerhouse with an estimated yearly revenue of $32 billion and nine iconic billion-dollar brands. The acquisition aims to combine their complementary product lines and market strengths, with completion expected in the second half of 2026.",
      "url": "https://www.wfmj.com/story/53209113/corporation-building-warren-plant-to-buy-maker-of-tylenol",
      "source": "WFMJ.com",
      "published": "20251103T144719",
      "overall_sentiment_score": 0.266676,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment_score": 0.107052,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 0.625587
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee replacement division into a stand-alone company named DePuy Synthes within the next 18 to 24 months. This move aims to allow J&J to concentrate on faster-growing businesses, as the orthopedics unit has lower growth and margins compared to other medical-device segments. The company will explore various separation options, including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqfXTu2F9QgCJ-CwSOI-cFfigKXCSj9w1IZd6-jcvyr27MabXi606mdG&gaa_ts=6908bb3a&gaa_sig=Sd2hP8jaZ4Al4uBnC33zfsOpzXhs0fstjxMToGedRZ8eymE0iPprUsoHNGvhomZJyMPseUU54XeF1eWgNyPHsw%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T141228",
      "overall_sentiment_score": 0.022507,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment_score": 0.005506,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 0.336276
    },
    {
      "title": "Johnson & Johnson to Split Off Orthopedics Business",
      "summary": "Johnson & Johnson announced plans to separate its artificial hip and knee business, DePuy Synthes, into a stand-alone company within 18 to 24 months. This move aims to focus J&J on faster-growing and higher-margin businesses, as the orthopedics division exhibits lower growth compared to other medical-device units. The company is exploring options for the separation, including a potential spinoff to shareholders.",
      "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62?gaa_at=eafs&gaa_n=AWEtsqfm9cnhJV4LxC5n76ed1k_XTc9dKq3n8PcYfSxNX1Bgp-QBa85kK2Vg&gaa_ts=6908e696&gaa_sig=qdezn18di0LjhLbIpkQdNF1irgsJThiHof1Rg9AWR_MWXTUe97iRamr0pMxmTVHZZkbWaqmV7An5oWIAfD52ZA%3D%3D",
      "source": "The Wall Street Journal",
      "published": "20251103T171735",
      "overall_sentiment_score": 0.012586,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment_score": 0.007139,
      "ticker_sentiment_label": "Neutral",
      "relevance_score": 0.323867
    }
  ]
}